Maven Bio
PrivateLast Round
Seed
Apr 17, 2025
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Maven Bio develops live intelligence software for biopharma teams. The platform monitors industry developments and maintains competitive views, asset screens, and recurring briefs with sourced updates and rollback. Its intelligence layer connects evidence across drugs, companies, trials, and deals, with access through its application, AI connectors, and API.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Vertical SaaS, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maven Bio Comparables
Compare Maven Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| One Zyme | 89% | |
| S&P Global Inc. | 76% | |
| BioCentury Inc. | 72% |
Maven Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 17, 2025 |
Maven Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NVO Capital | Seed |
| Pags Group | Seed |
| Y Combinator | Seed |
| Splash Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 66% MoM, reaching 12.1K.
- Jun 20, 2026
Monthly visitors increased 250% MoM, reaching 7.3K.
Maven Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Maven Bio's valuation, stock price, and market status.
Is Maven Bio a public or private company?
Maven Bio is a private company.
What is the current stock price of Maven Bio?
Maven Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Maven Bio worth (valuation)?
Valuation information for Maven Bio is not publicly available.
Can I buy Maven Bio stock?
Maven Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Maven Bio's last funding round?
Maven Bio's most recent funding round was Seed on April 17, 2025.
Who are the main investors in Maven Bio?
Key investors in Maven Bio include Y Combinator, Splash Capital.
Will Maven Bio IPO soon?
No public IPO plans have been announced for Maven Bio.
How can I track Maven Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Maven Bio's secondary market activity and sign up for updates.